Symbols / CMRA
CMRA Chart
About
Comera Life Sciences Holdings, Inc., a preclinical stage life sciences company, develops an internal portfolio of proprietary therapeutics that incorporate its proprietary formulation platform. Its SQore platform is designed to enable the conversion of intravenous biologics to subcutaneous versions. Comera Life Sciences Holdings, Inc. was founded in 2014 and is headquartered in Woburn, Massachusetts.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Biotechnology | Market Cap | 3.07K |
| Enterprise Value | 3.12M | Income | -9.35M | Sales | 1.00M |
| Book/sh | -0.14 | Cash/sh | 0.06 | Dividend Yield | — |
| Payout | 0.00% | Employees | 12 | IPO | — |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | 0.00 | P/B | -0.00 | P/C | — |
| EV/EBITDA | -0.41 | EV/Sales | 3.12 | Quick Ratio | 0.64 |
| Current Ratio | 0.90 | Debt/Eq | 549.04 | LT Debt/Eq | — |
| EPS (ttm) | -0.22 | EPS next Y | — | EPS Growth | — |
| Revenue Growth | -42.00% | Earnings | — | ROA | -119.35% |
| ROE | -16.29% | ROIC | — | Gross Margin | 73.52% |
| Oper. Margin | -15.82% | Profit Margin | 0.00% | Shs Outstand | 30.74M |
| Shs Float | 13.53M | Short Float | 1.36% | Short Ratio | 0.84 |
| Short Interest | — | 52W High | 0.00 | 52W Low | 0.00 |
| Beta | -81.01 | Avg Volume | 430.00 | Volume | 730.00 |
| Target Price | — | Recom | None | Prev Close | $0.00 |
| Price | $0.00 | Change | 0.00% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
$0.00
Latest analyst target
3. DCF / Fair value
$-1.75
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.00
Low
—
High
—
Mean
—
- Comera Life Sciences Appoints Janice Marie McCourt as Chief Business Officer - citybiz Wed, 09 Nov 2022 08
- Top 10 Stocks With Highest Insider Sentiment and Trading Activity - Nasdaq ue, 28 Feb 2023 08
- CMRA, The First Camera For Apple Watch, Debuts At CES 2017 - PR Newswire hu, 05 Jan 2017 08
- Help for the LEGO EV3 Robotics Teacher - Carnegie Mellon Robotics Academy - Carnegie Mellon University hu, 19 Aug 2021 07
- CMRA Presents 4th Annual Shogun 8-Hour Mini Endurance at Eagles Canyon Raceway - Motorcyclist Fri, 15 Apr 2011 07
- Village Idiots Come From Behind To Win CMRA "8 Hours Of Texas" At Texas World Speedway - Roadracing World Wed, 27 Mar 2013 07
- New 'CMRA' Band for Apple Watch Features Dual 2MP and 8MP Cameras - MacRumors Wed, 02 Nov 2016 07
- Updated Post: Sanchez Wraps Up CMRA Season With 11 Titles - Roadracing World ue, 14 Oct 2003 07
Insider Transactions
No recent insider transactions.
Financials
| Line Item | 2022-12-31 | 2021-12-31 |
|---|---|---|
| TaxEffectOfUnusualItems | 0.00 | 0.00 |
| TaxRateForCalcs | 0.00 | 0.00 |
| NormalizedEBITDA | -13.33M | -5.53M |
| TotalUnusualItems | -4.56M | 160.59K |
| TotalUnusualItemsExcludingGoodwill | -4.56M | 160.59K |
| NetIncomeFromContinuingOperationNetMinorityInterest | -18.00M | -5.45M |
| ReconciledDepreciation | 93.95K | 86.14K |
| ReconciledCostOfRevenue | 210.39K | 161.01K |
| EBITDA | -17.89M | -5.37M |
| EBIT | -17.98M | -5.45M |
| NetInterestIncome | -20.39K | 0.00 |
| InterestExpense | 20.39K | 0.00 |
| NormalizedIncome | -13.45M | -5.61M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -18.00M | -5.45M |
| TotalExpenses | 12.60M | 5.86M |
| TotalOperatingIncomeAsReported | -11.97M | -5.54M |
| DilutedAverageShares | 10.45M | 19.09M |
| BasicAverageShares | 10.45M | 19.09M |
| DilutedEPS | -1.76 | -0.29 |
| BasicEPS | -1.76 | -0.29 |
| DilutedNIAvailtoComStockholders | -18.38M | -5.45M |
| NetIncomeCommonStockholders | -18.38M | -5.45M |
| OtherunderPreferredStockDividend | 373.86K | 0.00 |
| NetIncome | -18.00M | -5.45M |
| NetIncomeIncludingNoncontrollingInterests | -18.00M | -5.45M |
| NetIncomeContinuousOperations | -18.00M | -5.45M |
| PretaxIncome | -18.00M | -5.45M |
| OtherIncomeExpense | -6.01M | 83.85K |
| OtherNonOperatingIncomeExpenses | -1.46M | -76.74K |
| SpecialIncomeCharges | -6.57M | 160.59K |
| OtherSpecialCharges | -160.59K | |
| RestructuringAndMergernAcquisition | 6.57M | 0.00 |
| GainOnSaleOfSecurity | 2.01M | |
| NetNonOperatingInterestIncomeExpense | -20.39K | 0.00 |
| InterestExpenseNonOperating | 20.39K | 0.00 |
| OperatingIncome | -11.97M | -5.54M |
| OperatingExpense | 12.39M | 5.69M |
| ResearchAndDevelopment | 1.74M | 1.75M |
| SellingGeneralAndAdministration | 10.65M | 3.94M |
| GeneralAndAdministrativeExpense | 10.65M | 3.94M |
| OtherGandA | 10.65M | 3.94M |
| GrossProfit | 422.71K | 158.82K |
| CostOfRevenue | 210.39K | 161.01K |
| TotalRevenue | 633.10K | 319.83K |
| OperatingRevenue | 633.10K | 319.83K |
| Line Item | 2022-12-31 | 2021-12-31 |
|---|---|---|
| OrdinarySharesNumber | 16.71M | 19.09M |
| ShareIssued | 16.71M | 19.09M |
| NetDebt | 8.96K | |
| TotalDebt | 319.49K | 323.06K |
| TangibleBookValue | -6.25M | -14.69M |
| InvestedCapital | -6.25M | -14.69M |
| WorkingCapital | -2.00M | 5.74M |
| NetTangibleAssets | -6.25M | -14.69M |
| CapitalLeaseObligations | 319.49K | 323.06K |
| CommonStockEquity | -6.25M | -14.69M |
| TotalCapitalization | -6.25M | -14.69M |
| TotalEquityGrossMinorityInterest | -6.25M | -14.69M |
| StockholdersEquity | -6.25M | -14.69M |
| RetainedEarnings | -34.90M | -16.90M |
| AdditionalPaidInCapital | 28.66M | 2.21M |
| CapitalStock | 1.67K | 31.00 |
| CommonStock | 1.67K | 31.00 |
| TotalLiabilitiesNetMinorityInterest | 9.97M | 22.10M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 4.92M | 21.06M |
| PreferredSecuritiesOutsideStockEquity | 4.52M | 20.86M |
| DerivativeProductLiabilities | 277.51K | 0.00 |
| LongTermDebtAndCapitalLeaseObligation | 120.30K | 201.50K |
| LongTermCapitalLeaseObligation | 120.30K | 201.50K |
| CurrentLiabilities | 5.06M | 1.05M |
| OtherCurrentLiabilities | 2.19M | 7.91K |
| CurrentDeferredLiabilities | 144.28K | 0.00 |
| CurrentDeferredRevenue | 144.28K | 0.00 |
| CurrentDebtAndCapitalLeaseObligation | 199.18K | 121.55K |
| CurrentCapitalLeaseObligation | 199.18K | 121.55K |
| CurrentDebt | 455.56K | |
| OtherCurrentBorrowings | 455.56K | |
| PensionandOtherPostRetirementBenefitPlansCurrent | 767.09K | 349.00K |
| PayablesAndAccruedExpenses | 1.76M | 566.64K |
| CurrentAccruedExpenses | 303.65K | 149.70K |
| Payables | 1.46M | 416.94K |
| AccountsPayable | 1.46M | 416.94K |
| TotalAssets | 3.73M | 7.42M |
| TotalNonCurrentAssets | 664.01K | 636.74K |
| OtherNonCurrentAssets | 50.00K | 50.00K |
| NonCurrentPrepaidAssets | 43.20K | 32.20K |
| NetPPE | 570.82K | 554.54K |
| AccumulatedDepreciation | -496.56K | -402.61K |
| GrossPPE | 1.07M | 957.15K |
| Leases | 9.41K | 17.97K |
| ConstructionInProgress | 88.36K | 0.00 |
| OtherProperties | 937.43K | 917.43K |
| MachineryFurnitureEquipment | 32.18K | 21.75K |
| Properties | 0.00 | 0.00 |
| CurrentAssets | 3.06M | 6.78M |
| OtherCurrentAssets | 72.89K | 49.38K |
| CurrentDeferredAssets | 90.05K | 0.00 |
| RestrictedCash | 1.51M | 0.00 |
| PrepaidAssets | 913.61K | 0.00 |
| Receivables | 34.32K | 221.55K |
| OtherReceivables | 221.27K | |
| DuefromRelatedPartiesCurrent | 0.00 | 286.00 |
| AccountsReceivable | 34.32K | 0.00 |
| CashCashEquivalentsAndShortTermInvestments | 446.61K | 6.51M |
| CashAndCashEquivalents | 446.61K | 6.51M |
| Line Item | 2022-12-31 | 2021-12-31 |
|---|---|---|
| FreeCashFlow | -9.80M | -3.90M |
| IssuanceOfDebt | 0.00 | 750.00K |
| IssuanceOfCapitalStock | 829.47K | 9.35M |
| CapitalExpenditure | -28.61K | -142.01K |
| EndCashPosition | 2.00M | 6.56M |
| BeginningCashPosition | 6.56M | 180.43K |
| ChangesInCash | -4.56M | 6.38M |
| FinancingCashFlow | 5.24M | 10.28M |
| CashFlowFromContinuingFinancingActivities | 5.24M | 10.28M |
| NetOtherFinancingCharges | 3.75M | |
| ProceedsFromStockOptionExercised | 660.65K | 180.00K |
| NetPreferredStockIssuance | 0.00 | 9.35M |
| PreferredStockIssuance | 0.00 | 9.35M |
| NetCommonStockIssuance | 829.47K | 0.00 |
| CommonStockIssuance | 829.47K | 0.00 |
| NetIssuancePaymentsOfDebt | 0.00 | 750.00K |
| NetLongTermDebtIssuance | 0.00 | 750.00K |
| LongTermDebtIssuance | 0.00 | 750.00K |
| InvestingCashFlow | -28.61K | -142.01K |
| CashFlowFromContinuingInvestingActivities | -28.61K | -142.01K |
| NetPPEPurchaseAndSale | -28.61K | -142.01K |
| PurchaseOfPPE | -28.61K | -142.01K |
| OperatingCashFlow | -9.77M | -3.76M |
| CashFlowFromContinuingOperatingActivities | -9.77M | -3.76M |
| ChangeInWorkingCapital | 2.55M | 574.20K |
| ChangeInOtherWorkingCapital | 144.28K | -28.95K |
| ChangeInPayablesAndAccruedExpense | 1.65M | 719.13K |
| ChangeInAccruedExpense | 789.15K | 399.80K |
| ChangeInPayable | 862.92K | 319.32K |
| ChangeInAccountPayable | 862.92K | 319.32K |
| ChangeInPrepaidAssets | 789.15K | -230.96K |
| ChangeInReceivables | -34.03K | 114.98K |
| ChangesInAccountReceivables | -34.32K | 109.87K |
| OtherNonCashItems | 7.22M | 79.42K |
| StockBasedCompensation | 375.79K | 1.11M |
| DepreciationAmortizationDepletion | 93.95K | 86.14K |
| DepreciationAndAmortization | 93.95K | 86.14K |
| Depreciation | 93.95K | 86.14K |
| OperatingGainsLosses | -2.01M | -160.59K |
| GainLossOnInvestmentSecurities | -2.01M | |
| GainLossOnSaleOfPPE | 0.00 | |
| NetIncomeFromContinuingOperations | -18.00M | -5.45M |
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Public Trades for CMRA
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|